Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


OMIX LIMS Multi-Lab Informatics Platform

Product Image
Product Description

Multi-Lab Informatics Platform for Life Sciences Research

The OMIX research platform from GenoLogics provides a highly configurable life sciences system for cross-science and multiple lab implementations. Today's life sciences research enterprises use more samples in ever more complex experiments, generating growing volumes of data. A robust informatics platform is crucial to improving operational efficiency, and for enhancing data management to publish meaningful results.
The OMIX’s built-in Lab Configuration Engine technology allows you to tailor the platform to fit your lab. You can configure this platform for a wide range of workflows from genomics and proteomics to cell biology, metabolomics, and imaging.

Multi-Lab Informatics Platform: Capabilities

• Tight integration to a wide range of instruments, applications, platforms, workflows and software
• The Automated Informatics framework provides automatic data capture and supports results parsing, contextual data integration and bioinformatics pipelining
• The Adaptive Reporting framework provides interactive reporting capabilities to query data from multiple sources and provide a holistic view of the data
• LabLink's secure Web-based collaboration portal allows you to streamline interactions with customers and researchers and optimize customer service levels

The OMIX platform accurately segments laboratory and project data to facilitate comprehensive implementations across multiple labs and science environments, and provides strong security and data archiving mechanisms to facilitate integrated analytics.

Multi-Lab Informatics Platform: Standards Compliance

The OMIX platform supports the compliance of many government regulations, including 21 CFR Part 11, 21 CFR Part 58 and HIPAA privacy laws.

OMIX is the underlying informatics platform that supports our science-purposed lab and data management solutions for genomics, next generation sequencing and proteomics.

Product OMIX LIMS Multi-Lab Informatics Platform
Company Genologics
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Genologics
Suite 2302 - 4464 Markham Street, Victoria, British Columbia, Canada, V8Z 7X8



Email: info@genologics.com



Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Designer Cell Fate Switches Could Streamline Stem Cell Biology
Researchers develop new method of reprogramming cells between cell types in a more efficient way than before.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
More Effective Strategy for Producing Flu Vaccines
Researchers have developed a virus backbone, allowing producers to grow vaccine viruses in mammalian cells, rather than in eggs.
Soil Carbon Release Might Equal U.S. Emissions
Research suggests 55M tons of carbon will be release from soils by 2050, 17% higher than prjected emissions.
Inspiring Futuristic Innovation: Brain ‘Organoids’
Scientists create artificial brains, providing an advanced model for studying brain tumour development.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Scroll Up
Scroll Down

Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!